269 filings
Page 8 of 14
8-K
iav7oa7jj0lhm8va
8 May 17
TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug Application
12:00am
8-K
mvkm11f5fb98kf577aj2
2 May 17
TherapeuticsMD Announces First Quarter 2017 Financial Results
12:00am
8-K
pteqf7t2urx65
10 Apr 17
TherapeuticsMD Provides TX-004HR Regulatory Update
12:00am
8-K
k56618wb41pps 3dip7
1 Mar 17
Regulation FD Disclosure
12:00am
8-K
g5o52ybthgm0
23 Feb 17
TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial Results
12:00am
8-K
0ys8zyz4
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
aau73g
8 Dec 16
1 TX - 001HR Supplemental Replenish Trial Design And Topline Phase 3 Results December 2016
12:00am
8-K
1fgrn31
5 Dec 16
Regulation FD Disclosure
12:00am
8-K
273snj2x9qg24x8yw
3 Nov 16
TherapeuticsMD Announces Third Quarter 2016 Financial Results
12:00am
8-K
gea 25hjkn4qn
26 Sep 16
Regulation FD Disclosure
12:00am
8-K
prs8q
19 Sep 16
Results of Operations and Financial Condition
12:00am
8-K
ra2drovtu hk
22 Aug 16
Regulation FD Disclosure
12:00am
8-K
90r 55xmo
4 Aug 16
TherapeuticsMD Announces Second Quarter 2016 Financial Results
12:00am
8-K
1qgh65cg hkvkgbj44
7 Jul 16
Regulation FD Disclosure
12:00am
8-K
vrk3fdyt 509n7ut175
29 Jun 16
TherapeuticsMD Announces Filing Timeline for Yuvvexy (TX-004HR) New Drug Application
12:00am
8-K
b1j1irpent86oym
20 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9eox4v7a 0nmdn9e
4 May 16
Regulation FD Disclosure
12:00am
8-K
3i7d8eymvcz w1
3 May 16
TherapeuticsMD Announces First Quarter 2016 Financial Results
12:00am
8-K
oqlnr51qy
7 Mar 16
Regulation FD Disclosure
12:00am
8-K
yb05gdsudwowb
25 Feb 16
TherapeuticsMD Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am